Covered recipient · General Payments record
KATE ELIZABETH MCCOLLUM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$1,130.94
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $526.31 | 34 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $186.48 | 12 |
| Novo Nordisk AS | $135.99 | 10 |
| PFIZER INC. | $100.06 | 6 |
| Acerta Pharma LLC | $41.67 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $39.12 | 2 |
| Exact Sciences Corporation | $22.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.26 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121457 | CMS |
| ABBVIE INC. | $22.33 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121461 | CMS |
| ABBVIE INC. | $23.93 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121465 | CMS |
| ABBVIE INC. | $12.63 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121469 | CMS |
| ABBVIE INC. | $11.85 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121473 | CMS |
| ABBVIE INC. | $15.21 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121477 | CMS |
| ABBVIE INC. | $14.38 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121481 | CMS |
| ABBVIE INC. | $23.41 | 08/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121485 | CMS |
| ABBVIE INC. | $4.77 | 09/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121489 | CMS |
| ABBVIE INC. | $14.78 | 10/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121493 | CMS |
| ABBVIE INC. | $15.73 | 10/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121497 | CMS |
| ABBVIE INC. | $15.20 | 12/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006121501 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.69 | 02/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015960783 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.03 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011584979 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.95 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014358399 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $23.07 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005594789 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $16.05 | 09/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005541281 | CMS |
| Exact Sciences Corporation | $22.99 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1027489821 | CMS |
| Novo Nordisk Inc | $16.73 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188946 | CMS |
| Novo Nordisk Inc | $13.33 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188893 | CMS |
| Novo Nordisk Inc | $16.62 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188934 | CMS |
| Novo Nordisk Inc | $14.07 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188907 | CMS |
| Novo Nordisk Inc | $9.38 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188855 | CMS |
| Novo Nordisk Inc | $10.01 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188869 | CMS |
| Novo Nordisk Inc | $4.09 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188841 | CMS |
| Novo Nordisk Inc | $14.19 | 08/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188923 | CMS |
| Novo Nordisk Inc | $25.00 | 09/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188959 | CMS |
| Novo Nordisk Inc | $12.57 | 11/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001188881 | CMS |
| PFIZER INC. | $16.09 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049414183 | CMS |
| PFIZER INC. | $16.92 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049744271 | CMS |
| PFIZER INC. | $18.38 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049352399 | CMS |
| PFIZER INC. | $15.45 | 09/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049622719 | CMS |
| PFIZER INC. | $18.46 | 11/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049662165 | CMS |
| PFIZER INC. | $14.76 | 12/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049730265 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.